Intrathecal Therapy May Slow Fatal Niemann-Pick Disease

Share this post

Intrathecal hydroxyproyl-beta-cyclodextrin appears to slow progression of cognitive and speech deficits. Hearing loss was a notable adverse event but was ‘manageable’ in this devastating disease, say investigators.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply